Tumor–stromal cross-talk modulating the therapeutic response in pancreatic cancer-Reference-Cited by-同舟云学术

Tumor–stromal cross-talk modulating the therapeutic response in pancreatic cancer

Published:2018-10 Issue:5 Volume:17 Page:461-472
ISSN:1499-3872
Container-title:Hepatobiliary & Pancreatic Diseases International
language:en
Short-container-title:Hepatobiliary & Pancreatic Diseases International

Author:

Neumann Christopher C.M.,von Hörschelmann Ellen,Reutzel-Selke Anja,Seidel Elisabeth,Sauer Igor Maximilian,Pratschke Johann,Bahra Marcus,Schmuck Rosa Bianca

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference54 articles.

1. Survival improvement in patients with pancreatic cancer by decade: a period analysis of the SEER database, 1981–2010;Sun;Sci Rep,2014

2. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

3. Pancreatic cancer;Vincent;Lancet,2011

4. Pancreatic cancer stromal biology and therapy;Xie;Genes Dis,2015

5. Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta;Müerköster;Cancer Res,2004

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SLC7A11 and the glutathione pathway as novel prognostic markers in resectable pancreatic ductal adenocarcinoma: A metabolomics study of clinical specimens;Pancreatology;2024-08

2. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities;Cancer Letters;2024-06

3. An Update on Gemcitabine-Based Chemosensitization Strategies in Pancreatic Ductal Adenocarcinoma;Frontiers in Bioscience-Landmark;2023-12-29

4. Potential mechanisms of cancer-associated fibroblasts in therapeutic resistance;Biomedicine & Pharmacotherapy;2023-10

5. A nomogram based on CT texture features to predict the response of patients with advanced pancreatic cancer treated with chemotherapy;BMC Gastroenterology;2023-08-10